Bipolar I vs Bipolar II: Differences in Episodes, Diagnosis, and Course
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Bipolar I disorder and bipolar II disorder are distinct diagnoses within the bipolar and related disorders group. Both involve changes in mood, energy, activity, and functioning that occur as recognizable clinical episodes. Their central diagnostic difference is the presence or absence of mania. Bipolar I requires a lifetime history of at least one manic episode. Bipolar II requires both at least one hypomanic episode and at least one major depressive episode, with no lifetime manic episode. These definitions are established in the National Institute of Mental Health clinical overview and the DSM-5 bipolar II comparison published by NCBI. For the complete classification of related diagnoses, read Types of Bipolar Disorder.
The distinction matters because mania and hypomania differ in duration, consequences, and degree of impairment, while depression may be prolonged and disabling in either disorder. Bipolar II should not be described as a universally mild form of bipolar I. Severity is evaluated across the whole longitudinal illness: depressive burden, functioning, safety, recurrence, other conditions, and response to care. A clinical diagnosis requires a detailed history, often supplemented by the observations of people who knew the individual during an episode. Mood swings or an online screening score are insufficient.
For additional clinical context, see Bipolar Depression vs Major Depression: Diagnosis and Treatment Differences.
Bipolar I vs bipolar II: the defining differences
Bipolar I: a clinician must establish at least one qualifying manic episode. Depressive episodes frequently occur but are not mandatory for the diagnosis. Hypomania may also occur. Manic episodes may involve marked functional impairment, psychosis, or hospitalization.
Bipolar II: a clinician must establish at least one qualifying hypomanic episode and one major depressive episode, and exclude any past manic episode. Hypomania creates an observable shift from usual functioning but is not accompanied by the marked impairment, episode-related hospitalization, or psychosis that defines mania. Major depressive episodes may be substantial and recurrent.
Both: individuals may experience depressive symptoms, disturbances in sleep and activity, mixed features, difficulties between full episodes, comorbid psychiatric or medical conditions, and a need for long-term treatment. Episode histories differ from person to person. The numeric subtype is not a numerical rating of illness severity. See NIMH and the 2023 VA/DoD guideline.
Mania versus hypomania
A manic episode is a distinct period of unusually elevated, expansive, or irritable mood and increased energy or activity, accompanied by symptoms such as decreased need for sleep, inflated self-esteem or grandiosity, pressured speech, rapidly changing thoughts, distractibility, increased goal-directed activity, or excessive engagement in risky activities. Under DSM-5-TR criteria, the episode usually lasts at least seven days and is present most of the day nearly every day; any duration can meet the duration requirement when hospitalization is necessary. Severity must involve marked impairment, hospitalization to prevent harm, or psychotic features. Alternative causes such as substances, medications, and medical conditions require assessment. For the diagnosis-specific overview, see Bipolar I Disorder.
A hypomanic episode involves the same broad family of mood and activation symptoms, but under DSM-5-TR rules it lasts at least four consecutive days, represents an unequivocal change from baseline, and is observable by others. It does not produce the marked impairment or necessitate hospitalization because of the elevated episode, and psychotic features are absent. If psychosis occurs with the elevated episode, the episode is manic by definition. Duration thresholds organize clinical diagnosis; they do not imply that shorter periods should be ignored. NIMH and NICE CG185 support careful episode-based assessment. For a detailed discussion of episodes, see Hypomania.
Consider two people who suddenly sleep very little, speak faster, and initiate multiple projects. One may remain able to function and later describe several days of unusually high productivity; another may spend beyond available resources, develop grandiose delusions, and need hospital care. The surface symptoms overlap, but episode severity and consequences differ substantially. No short anecdote permits formal diagnosis. Clinicians examine duration, symptom combinations, observable change, safety, substance exposure, and medical context.
A decreased need for sleep is also different from insomnia. A person who sleeps three hours and feels fully energized may describe reduced sleep need; someone who lies awake all night and feels exhausted describes something different. Neither sign on its own demonstrates mania or hypomania.
Is bipolar II a less severe form of bipolar I?
The high-mood episode in bipolar II is less severe than mania by diagnostic definition. The overall disorder can nevertheless be highly burdensome. Bipolar II is often associated with substantial recurrent depressive illness, long periods with residual depressive symptoms, and serious problems with functioning. One individual with bipolar I may spend years stable after a manic episode, while another individual with bipolar II may experience prolonged depression and repeated crises. The diagnosis alone cannot forecast either person's future.
A major prospective comparison followed 135 bipolar I and 71 bipolar II patients with weekly symptom ratings across up to 20 years. People with either diagnosis experienced symptoms during a substantial portion of observed weeks, approximately 46.6% in bipolar I and 55.8% in bipolar II in that study. The bipolar II course was particularly depression dominated. These are findings from one historical clinical cohort, not individualized predictions or a universal modern prevalence statistic. See Judd et al. (2003).
A 2024 systematic review and meta-analysis of completed suicide found that the pooled comparison did not demonstrate a difference between bipolar I and II; the odds ratio for bipolar II compared with bipolar I was 1.00, with a 95% confidence interval of 0.75–1.34. The number of available studies was small and methods heterogeneous, so precise comparative estimates remain uncertain. The study reinforces that clinical safety assessment matters in both subtypes.
Can bipolar I occur without depression?
Yes. Under DSM-5-TR, a qualifying manic episode establishes the essential episode requirement for bipolar I, even when the person has never had a major depressive episode. Depressive episodes are common in bipolar I, and they may precede the first recognized mania, but they are not obligatory. Bipolar II, in contrast, requires at least one major depressive episode as well as a hypomanic episode and the absence of mania. A person who has had only depression and ordinary ups and downs does not meet the bipolar II definition on that basis alone. See the official NIMH description and the DSM-5 diagnostic comparison. For the broader clinical picture, see Bipolar II Disorder.
Duration and impairment: what the episode criteria mean
Mania
The usual minimum is seven days unless the clinical episode necessitates hospitalization. The condition involves distinctly increased energy and mood disturbance with sufficient severity to cause marked impairment, require hospital care, or have psychotic features. Severe mania may interfere with realistic decision-making, finances, relationships, work, personal safety, and basic needs. Emergency assessment may be necessary independently of the final subtype determination.
Hypomania
At least four consecutive days of qualifying change are required by DSM-5-TR. Other people can observe the change in behavior and functioning. Some individuals experience the episode as enjoyable or productive and seek help only when depression returns. Others experience irritable hypomania, impulsive decisions, strained relationships, or distress without meeting the severity threshold for mania. A short-lived burst of enthusiasm or stress-related sleeplessness is not equivalent to a qualifying hypomanic episode.
Major depression
A major depressive episode normally lasts at least two weeks and involves persistent depressed mood or loss of interest together with other qualifying symptoms, clinically meaningful distress, or impairment. Depressive episodes may include fatigue, disrupted sleep or appetite, impaired concentration, guilt, hopelessness, and suicidal thoughts. Depression can look similar in bipolar I, bipolar II, and major depressive disorder; the longitudinal elevated-episode history determines whether a bipolar diagnosis applies. NIMH explains the symptom patterns.
Psychosis, mixed features, and rapid cycling
Psychosis can occur during mania and during major depressive episodes. If hallucinations or delusions occur during an elevated episode otherwise thought to be hypomanic, that elevated episode is manic and the bipolar I distinction becomes relevant. Psychotic depression can occur in bipolar II without proving prior mania. A specialist examines whether psychotic symptoms occurred only during mood episodes or outside them because that chronology matters in distinguishing bipolar and schizophrenia-spectrum conditions. NICE recommends explicit differential assessment.
Mixed features mean that symptoms associated with the opposite mood polarity accompany a qualifying episode. A person with depression may concurrently have increased energy or racing thoughts; mania or hypomania may include depressive symptoms. Mixed features can occur in either bipolar type and may complicate treatment choices. The CANMAT/ISBD guidelines distinguish treatment considerations for these presentations.
Rapid cycling is a course specifier generally referring to four or more qualifying mood episodes within a twelve-month period, with appropriate periods of remission or a change in episode polarity. It can be present in either type and does not mean that everyday emotions shift four times in an afternoon. The distinction between full episodes and within-day fluctuations is important when discussing mood changes in clinical care. NIMH.
How psychiatrists diagnose bipolar I and bipolar II
Diagnosis involves reconstructing episodes across the lifespan instead of deciding solely from the mood someone has during one appointment. Clinicians ask about age at onset, characteristic changes in mood and activity, episode duration, sleep need, unusual impulsivity, effects on work and relationships, hospitalization, psychotic symptoms, depressive periods, and recovery between episodes. They assess suicidality, medical history, medication exposure, substances, family history, and co-occurring conditions. With the person's consent, relevant observations from family members or friends and previous medical records can help verify episodes that were not recognized at the time. These are central recommendations in NICE CG185. Our English Hub assessment guide expands on this process: How Is Bipolar Disorder Diagnosed?.
A careful timeline can identify recurrent depression before the first known manic episode, a past hypomanic period mistaken for simply feeling well, or a medication-related change requiring alternative interpretation. The diagnosis can be revised when better information or a new episode emerges. Clinicians may also need to check thyroid function or investigate other physical explanations. There is no routine blood test, genetic test, or brain scan that independently confirms bipolar I or bipolar II. NIMH.
Do screening tools distinguish bipolar I from bipolar II?
Screening tools such as the Mood Disorder Questionnaire and Hypomania Checklist can organize conversations about symptoms, but results are not diagnostic verdicts. They cannot establish episode duration, impairment, alternate explanations, or the full psychiatric history without clinical assessment. Their diagnostic performance changes across patient groups and settings. NICE specifically advises against identifying bipolar disorder using questionnaires in primary care and recommends evaluating possible past elevated episodes. For more on the tools and their limitations, read Bipolar Disorder Screening Tests.
Why can bipolar II be missed?
Depression commonly drives the initial request for care, while hypomania may be recalled as a period of normal energy, achievement, or sociability. A person might not report the episode unless specifically asked about unusual reductions in sleep need, changes in activity, impulsive behavior, and observations from others. Family members may recall changes the individual regarded as positive. Such histories can help explain why clinicians sometimes reconsider a prior diagnosis of recurrent unipolar depression. NIMH.
Bipolar I versus bipolar II over the long term
Both disorders can recur, and both may involve symptoms between episodes that do not meet full diagnostic thresholds. Treatment response, severity of depression, sleep instability, other medical problems, substance use, available support, and continuing care all contribute to functioning. The historic longitudinal studies indicate that depressive morbidity can be prominent in either subtype and may dominate the observed course of bipolar II. Those studies are best read as population-level evidence, not a calendar of episodes that every individual will experience. Judd et al..
Can bipolar II change to bipolar I?
Yes. If a person with a previous bipolar II diagnosis experiences a verified manic episode, the clinician will ordinarily update the subtype to bipolar I. This reclassification reflects an additional lifetime episode. It is not inevitable for everyone with bipolar II. In one selected longitudinal sample of college-age people with bipolar-spectrum conditions, 17.4% of those originally diagnosed with bipolar II experienced conversion to bipolar I over approximately four and a half years. The sample was specifically recruited for bipolar-spectrum vulnerability; that figure should not be interpreted as the general population's lifetime risk. Alloy et al. (2012).
Earlier long-term research also documented the relative stability of bipolar diagnostic distinctions over follow-up while allowing for some classification changes. In practice, clinicians revisit the diagnosis when evidence changes rather than presuming that bipolar II must become bipolar I. Long-term diagnostic stability study.
Do the conditions have different causes?
Familial vulnerability, genetic contributions, disrupted circadian rhythms, sleep change, stress, and other biological and environmental factors have been studied across bipolar disorders. No known single cause, laboratory marker, or imaging result reliably separates the types in routine clinical practice. The clinical categories rest on lifetime episode histories. NIMH describes current scientific understanding of multiple interacting risk factors.
Conditions that complicate the comparison
Major depressive disorder shares many depressive symptoms with bipolar disorders but lacks documented mania or hypomania. Borderline personality disorder may involve intense emotional reactivity and difficulties in relationships, requiring assessment of interpersonal patterns and context rather than labeling all mood shifts as episodes. ADHD can feature longstanding attention and impulse-control difficulties that may resemble activation but often persist outside discrete mood episodes. Anxiety disorders, OCD, trauma-related conditions, sleep disorders, and substance use may coexist with bipolar illness or contribute overlapping symptoms.
Clinicians also assess stimulants, antidepressants, corticosteroids, alcohol and other substances, thyroid disease, and other medical explanations. The presence of a co-occurring condition does not invalidate bipolar disorder, and an apparent manic-like symptom does not necessarily establish bipolar disorder. Distinguishing episodic illness from enduring patterns and physiological exposures is a central task of differential diagnosis. NICE diagnostic guidance. For a specific comparison, read OCD vs Bipolar Disorder.
Treatment differences: phase, evidence, and safety
Bipolar I and bipolar II share some treatments but require phase-specific evaluation. Evidence for stopping acute mania cannot automatically be extended to acute bipolar depression; data from bipolar I trials cannot automatically establish efficacy in bipolar II. Medication selection depends on previous episodes, prior response, co-occurring medical conditions, interactions, patient preference, adverse effects, and safety. The 2023 VA/DoD guideline, NICE, and CANMAT/ISBD 2023 update offer complementary clinical frameworks.
Acute mania and hypomania
Severe acute mania may require antipsychotic treatment, a mood stabilizer, and close psychiatric monitoring, sometimes in a hospital. The urgency depends on symptoms and immediate risk, not only a diagnostic label. Hypomania does not automatically demand the same acute interventions; recurrent or impairing activation calls for specialist review, medication assessment, and careful follow-up. NICE acute mania recommendations and CANMAT/ISBD.
Acute bipolar depression
Treatment evidence differs by subtype. In the 2023 CANMAT/ISBD recommendations, quetiapine is the sole first-line treatment listed for acute bipolar II depression; lithium, lamotrigine, selected antidepressants, and other interventions are placed in later lines according to evidence and clinical circumstances. Bipolar I depression has a different first-line hierarchy, including multiple medications and combinations. Some approvals, evidence bases, and recommended uses also vary by jurisdiction.
Antidepressants require individualized consideration because switching to elevated states or mixed symptoms can be a concern. CANMAT/ISBD advises against antidepressant monotherapy in bipolar I depression and discusses carefully selected later-line antidepressants for nonmixed bipolar II depression. These clinical classifications do not justify starting or discontinuing medication without the prescribing clinician. CANMAT/ISBD 2023.
Maintenance treatment and psychological care
Long-term management aims to reduce recurrence and support functioning, often using continuing medication, bipolar-specific psychoeducation or psychotherapy, regular sleep and daily routines, and an individualized early-warning and crisis plan. CANMAT/ISBD identifies quetiapine, lithium, and lamotrigine among its first-line options for bipolar II maintenance, while maintenance strategies after bipolar I mania reflect the individual's manic and depressive history. Psychological support can address stress, relationships, adherence, and relapse prevention alongside appropriate medical care. CANMAT/ISBD; NICE.
Medication risks also matter. Lithium treatment involves blood-level and kidney/thyroid monitoring and attention to interactions or toxicity. Lamotrigine requires careful dose escalation and prompt evaluation of serious rashes. Valproate presents major fetal and reproductive safety risks, with jurisdiction-specific regulatory restrictions. Antipsychotics warrant attention to metabolic, weight, movement-related, and other adverse effects. Medication suitability and monitoring are patient-specific; treatment should be changed with professional oversight. NICE medication monitoring and safety guidance.
When to seek urgent help
Possible severe mania, psychosis, dangerous impulsivity, inability to meet basic needs, a rapidly deteriorating mental state, or suicidal thoughts with intent or immediate safety risk require urgent assessment. Contact local emergency services or an emergency department when there is imminent danger. In the United States, the 988 Suicide & Crisis Lifeline provides crisis support. A clinician can evaluate safety and determine appropriate care before diagnostic uncertainty is fully resolved. NICE urgent referral and risk guidance.
For loved ones, concrete observations are usually more helpful than arguing over labels: note marked changes in sleep, spending, speech, activity, risky behavior, or hopelessness; support timely access to care; and participate in a crisis plan when the individual agrees. Safety needs arise in both bipolar types.
Particular considerations across the lifespan
Children and adolescents require a specialist developmental and longitudinal assessment. Normal developmental variability, ADHD, and other conditions complicate recognition, and adult treatment evidence cannot simply be extrapolated to young people. Older adults with new manic-like symptoms need careful review for physical disease, medication effects, and cognitive changes. Pregnancy and the postpartum period demand individualized planning of relapse prevention and medication safety; valproate in particular requires strict attention to reproductive risks and applicable regulation. NICE directs clinicians to tailored guidance for these populations.
Practical implications for living with either type
People can work with clinicians to build an episode timeline, document sleep and mood patterns, recognize their personal warning signs, review medication effects, and plan communication with trusted supporters. A mood diary is a way to record information for care, not a diagnostic test. Regular sleep opportunities, follow-up appointments, monitoring, and prompt attention to escalating mood change can help the treatment plan remain responsive. The person's own goals for work, relationships, independence, and quality of life belong in shared decision making. NICE recovery-planning recommendations.
Frequently asked questions
Is bipolar I more serious than bipolar II?
Mania is more severe than hypomania by definition, but overall illness burden varies. Bipolar II can involve extensive depression and significant suicide risk. The numeric type does not measure an individual's functioning or suffering. Prospective course comparison; 2024 systematic review.
Can a person with bipolar II be hospitalized?
Yes. Severe depression, psychotic depression, suicidal risk, or other safety concerns may require inpatient care. Hospitalization for an elevated manic episode instead supports classifying that episode as mania and reassessing the bipolar type. Hospitalization alone, without knowing its reason, does not establish bipolar I.
Does bipolar I always include manic and depressive episodes?
No. A manic episode is required for bipolar I; a major depressive episode is common but not required. NIMH.
Can bipolar II include psychotic symptoms?
Psychotic features can occur during a depressive episode in bipolar II. Psychosis during an elevated episode means that elevated episode is manic rather than hypomanic and changes the bipolar-subtype assessment.
Does hypomania always feel good?
No. Some episodes involve euphoria or productivity, while others involve pronounced irritability, tension, excessive activity, or regrettable decisions. The full episode pattern matters more than whether the experience felt positive.
Can bipolar II become bipolar I?
If a genuine manic episode later occurs, the clinician changes the lifetime classification to bipolar I. This outcome is possible, not inevitable. Alloy et al..
Can a test determine bipolar I or II?
No. Screening instruments can prompt clinical discussion, but a diagnosis requires historical evaluation of episodes, severity, impairment, alternative causes, and co-occurring conditions. NICE.
Are bipolar I and II treated with identical medications?
Some options overlap; indications and evidence vary by type, episode phase, and individual factors. Acute mania, bipolar depression, and maintenance have different evidence bases. CANMAT/ISBD.
Is long-term recovery possible?
Meaningful recovery, sustained functioning, and long periods of stable mood are possible. An individualized plan for maintenance, monitoring, and timely response to recurrent symptoms is often important for both conditions. NICE.
Related Articles
References
Alloy, L. B., et al. (2012). Progression along the bipolar spectrum: A longitudinal study of predictors of conversion from bipolar spectrum conditions to bipolar I and II disorders. Journal of Abnormal Psychology, 121(1), 16–27. https://doi.org/10.1037/a0023973.
Dev, D. A., et al. (2024). Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysis. Journal of Affective Disorders, 361, 480–488. https://doi.org/10.1016/j.jad.2024.06.045.
Judd, L. L., et al. (2003). Long-term symptomatic status of bipolar I vs. bipolar II disorders. International Journal of Neuropsychopharmacology, 6(2), 127–137. https://doi.org/10.1017/S1461145703003341.
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009.
National Institute for Health and Care Excellence. (2014; updated). Bipolar disorder: Assessment and management (CG185). https://www.nice.org.uk/guidance/cg185/chapter/recommendations.
National Institute of Mental Health. (n.d.). Bipolar disorder. https://www.nimh.nih.gov/health/publications/bipolar-disorder.
Substance Abuse and Mental Health Services Administration. (2016). DSM-5 bipolar II disorder comparison. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t23/.
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for the management of bipolar disorder. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/mh/bd/index.asp.